Investigational new drug company code: BGS649
CBGS649A2204
Phase 2 small_molecule terminated
Quick answer
Investigational new drug company code: BGS649 for Obese Hypogonadotropic Hypogonadism is a Phase 2 program (small_molecule) at Mereo BioPharma Group plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Mereo BioPharma Group plc
- Indication
- Obese Hypogonadotropic Hypogonadism
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated